Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy (Q28208442)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 15 June 2003)
edit
Language Label Description Also known as
English
Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy
scientific article (publication date: 15 June 2003)

    Statements

    Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy (English)
    0 references
    0 references
    Linda S Elting
    0 references
    David V Hudson
    0 references
    Edward B Rubenstein
    0 references
    15 June 2003
    0 references
    0 references
    97
    0 references
    12
    0 references
    3099-106
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit